Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario

Johns Hopkins Joins Cancer AI Alliance

Levindale Named One of Newsweek’s “Best Nursing Homes” for Third Year in a Row

RXNT Acquires Scalabull

TNF Pharmaceuticals Secures Strategic Equity Investment from Prevail Partners

Emergent BioSolutions Closes $100 Million Financing

T. Rowe Price Funds Join $175M Series B for Aktis Oncology

Novavax Names Dr. Ruxandra Draghia-Akli as Executive Vice President and Head of Research & Development

Emergent BioSolutions Confirms Approximately $400 Million in Orders in 2024 & 2025

VerImmune Closes $4.5 Million Pre-Series A Financing

Luminis Health Doctors Community Medical Center Hosts Annual Pink Ribbon Rally to Celebrate Survivors and Raise Awareness

Orgenesis Announces Reverse Stock Split

Maternal Health Startup Canopie Raises $3.7 Million

VaLogic Bio Acquires Facility Logix

CareFirst Appoints Crystal Calloway Mitchell as VP of Communications

Revolutionizing Access to Futuristic Medicine: Gene Therapies for All